L04AC04 · Antineoplastic and immunomodulating agents
Rilonacept FGK Representative Service GmbH
Indications
Treatment of idiopathic pericarditis
Composition
- Active substance
- rilonacept
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Rilonacept FGK Representative Service GmbH
- Active substance
- rilonacept
- ATC code
- L04AC04
- Therapeutic area
- Pericarditis
- Marketing authorisation holder
- Rilonacept FGK Representative Service GmbH
- Status
- Application withdrawn
- EMA product number
- EMEA/H/C/006537